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Abstract
The upper respiratory tract microbiome has an important role in respiratory health. Influenza A is a common viral
infection that challenges that health, and a well-recognized sequela is bacterial pneumonia. Given this connection,
we sought to characterize the upper respiratory tract microbiota of individuals suffering from the pandemic H1N1
influenza A outbreak of 2009 and determine if microbiome profiles could be correlated with patient characteristics.
We determined the microbial profiles of 65 samples from H1N1 patients by cpn60 universal target amplification and
sequencing. Profiles were examined at the phylum and nearest neighbor “species” levels using the characteristics of
patient gender, age, originating health authority, sample type and designation (STAT/non-STAT). At the phylum level,
Actinobacteria-, Firmicutes- and Proteobacteria-dominated microbiomes were observed, with none of the patient
characteristics showing significant profile composition differences. At the nearest neighbor “species” level, the upper
respiratory tract microbiomes were composed of 13-20 “species” and showed a trend towards increasing diversity
with patient age. Interestingly, at an individual level, most patients had one to three organisms dominant in their
microbiota. A limited number of discrete microbiome profiles were observed, shared among influenza patients
regardless of patient status variables. To assess the validity of analyses derived from sequence read abundance,
several bacterial species were quantified by quantitative PCR and compared to the abundance of cpn60 sequence
read counts obtained in the study. A strong positive correlation between read abundance and absolute bacterial
quantification was observed. This study represents the first examination of the upper respiratory tract microbiome
using a target other than the 16S rRNA gene and to our knowledge, the first thorough examination of this microbiome
during a viral infection.
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Introduction
In 2009, a novel H1N1 influenza A strain (A(H1N1) pdm09)
reached global pandemic status. It is estimated that tens of
millions to 200 million people were infected with A(H1N1)
pdm09 worldwide, with 2-5% of confirmed cases in Canada
and the USA requiring hospitalization [1,2]. Although many
hospitalizations and deaths could be attributed to recognized
risk factors (cardiovascular disease, respiratory diseases, auto-
immune disorders, obesity, diabetes, cancer or pregnancy),
close to one third of hospitalized patients who died had no
known underlying medical conditions that would have
predisposed them to severe infection [1]. The last major
pandemic of an H1N1 influenza A strain was the Spanish flu of
1918-19. Recent investigations into that outbreak have
determined that for many patients, if not most, secondary
infection with bacterial pneumonia was the major cause of
morbidity and mortality [3]. Along a similar vein, current
research has shown that Streptococcus pneumoniae
coinfection is correlated with severity of A(H1N1) pdm09
influenza illness [4]. These findings highlight the importance of
bacteria in the respiratory tract during a viral infection.
However, research into the associations of bacteria with
A(H1N1) pdm09 infections has to date focused only on known
pathogens.
The normal upper respiratory tract microbiota of humans has
not received the same intense study as other body sites;
nevertheless, a basic picture of this community has emerged.
The current consensus is that a healthy nose/nasopharynx has
a bacterial community dominated by Actinobacteria and
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Firmicutes, with an increasing presence of Proteobacteria
farther from the nose in the nasopharynx [5–8]. An inverse
correlation between the prevalence of Actinobacteria and
Firmicutes has been noted, with individuals having
microbiomes dominated by either one phylum or the other,
suggesting a possible antagonistic relationship between the
groups [7]. At the genus level, similar to skin microbiomes,
Corynebacterium spp., Propionibacterium spp. and
Staphylococcus spp. are prominent members of the upper
respiratory tract microbiome [6,7,9]. However, despite our
growing understanding, we do not yet know if any particular
upper respiratory tract microbiota compositions are associated
with particular patient characteristics during a respiratory tract
infection.
In the context of A(H1N1) pdm09, one study briefly examined
the upper respiratory microbiota of 2009 A(H1N1) pdm09
patients while doing a metagenomic analysis of RNA from
nasopharyngeal swabs of 17 individuals [10]. Although the
focus of that work was to examine the viral component of the
microbiome, a small fraction of bacterial ribosomal RNA (rRNA)
sequences were also detected. Interestingly, the most detected
bacterial families observed in individual patients were
Enterobacteriaceae (Proteobacteria, 7 patients), Moraxellaceae
(Proteobacteria, 4 patients), Streptococcaceae (Firmicutes, 2
patients), Carnobacteriaceae (Firmicutes, 2 patients),
Pasteurellaceae (Proteobacteria, 1 patient), and
Oxalobacteraceae (Proteobacteria, 1 patient) [10]. This
composition is notably different from previous studies (more
Proteobacteria-dominated profiles, no Actinobacteria-
dominated profiles) and raises the question of whether this
represents a methodological difference or an actual difference
in the upper respiratory microbiota during A(H1N1) pdm09
infection compared to healthy individuals.
The goal of the current study was to characterize the
organisms present in the upper respiratory tract of a range of
individuals during A(H1N1) pdm09 infection. We obtained
samples from A(H1N1) pdm09 patients in British Columbia,
Canada during the 2009 pandemic and determined their
microbiome compositions by metagenomic profiling with the
cpn60 universal target and qPCR. We found the microbiomes
clustered based on composition into a few recurring profiles
that were independent of patient gender, age, originating health
authority, sample type collected or its STAT/non-STAT
designation. In addition, we found the number of metagenomic
sequence reads obtained correlated strongly with absolute
qPCR quantification for seven species that were present at a
range of prevalences in the data. This confirmed that
metagenomic sequence frequencies obtained from the cpn60
gene accurately reflected the composition of the samples.
Materials and Methods
Ethics statement
Samples were selected from a larger study examining the
spatio-temporal distribution of A(H1N1) pdm09 across British
Columbia during the 2009 pandemic. Identifying data was
stripped from the sample record, leaving only patient gender,
age, regional health authority, specimen type and STAT/non-
STAT designation. The study was approved by the University
of British Columbia Clinical Research Ethics Board (Protocols
B09-0284 and H09-02695).
Sample collection
A total of 67 clinical samples sent to the British Columbia
Public Health Microbiology and Reference Laboratory (BC
PHMRL) between April 24, 2009 and March 29, 2010 for
influenza A testing were selected. All samples were confirmed
A(H1N1) pdm09-positive by RT-PCR and sequencing at the
BC PHMRL. Samples were collected by physicians at clinics
and hospitals in the Fraser (n=11), Northern (n=13), Vancouver
Island (n=8), Vancouver Coastal (n=12) and Interior (n=23)
health authorities in British Columbia, Canada. Clinical
specimens were chosen for the microbiome study to reflect the
type and proportion of samples received for H1N1 testing by
the BC PHMRL and included nasal swabs (n=23),
nasopharyngeal swabs (n=32), nasopharyngeal washes (n=11)
and tracheal aspirates (n=1). Patients included both genders
(male=33, female=33, undefined=1) and ranged in age from <1
to 89 years. Samples were collected in hospitals (“STAT”
designation, n=35) or non-hospital, community settings (“non-
STAT”, n=32) (Table S1).
Nucleic acid extraction
Samples were received at the BC PHMRL through standard
clinical sample submission protocols. Total nucleic acid was
extracted from clinical material by MagMAX™ Viral RNA
Isolation Kit (Life Technologies, Burlington, ON, Canada).
Isolated nucleic acid (DNA and RNA) was precipitated for
storage and transport. Nucleic acid was re-suspended in 100 µl
of TE buffer (10 mM Tris-HCl, 1 mM EDTA; pH 8.0) prior to
analysis.
cpn60 universal target (UT) PCR and pyrosequencing
The universal target (UT) region of the cpn60 gene was
amplified using a primer cocktail consisting of a 1: 3 molar ratio
of primers H279/H280:H1612/H1613 (Table 1) [11–13]. Primer
sets were modified at the 5' end with 10-mer multiplexing
identification (MID) sequence as per pyrosequencing
recommendations to facilitate multiplexing of samples for
sequencing (Roche, Brandford CT, USA). PCR reactions
consisted of 1 × PCR reaction buffer (20 mM Tris-HCl (pH 8.4),
50 mM KCl), 2.5 mM MgCl2, 200 µM dNTP, 800 nM of primer
cocktail, 2.5 U Platinum Taq DNA Polymerase (Invitrogen,
Burlington, ON, Canada) and 2 µl template DNA, in a final
volume of 50 µl. Twelve PCR reactions were run for each
sample in a thermocycler (Eppendorf Mastercycler) over a
temperature gradient: 94°C for 3 min, followed by 40 cycles of
30 sec at 94°C, 1 min at 42-60°C and 1 min at 72°C, followed
by a final extension at 72°C for 10 min. PCR reactions from the
same sample were pooled and concentrated using the AMPure
Purification system (Agencourt Bioscience, Beverly, MA, USA),
and further purified by agarose gel separation and extraction
(QIAEX II gel extraction kit, Qiagen, Toronto, ON, Canada).
Final amplicon was suspended in TE buffer and quantified
using a Qubit fluorometer (Invitrogen). cpn60 UT amplicon
libraries were pooled in equimolar concentrations and
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sequenced using the GS FLX Titanium system as per
manufacturer’s instructions.
DNA sequence quality control and assembly of OTU
Pyrosequencing data was processed using the default on-rig
procedures from 454/Roche. Filter passed reads were
assessed for non-cpn60 host DNA by screening against a
database comprised of the human genome with annotated
cpn60 genes and predicted pseudo-genes removed. MID-
partitioned sequences were processed with the microbial
Profiling Using Metagenomic Assembly (mPUMA) pipeline
(http://mpuma.sourceforge.net [14]) to generate operational
taxonomic units (OTU) with gsAssembler (Roche). OTU were
screened and filtered for chimeras with Chaban’s Chimera
Checker (C3) (http://mpuma.sourceforge.net) and Bellerophon
[15]. Remaining OTU were identified by watered-Blast
comparison [12] to the cpn60 reference database, cpnDB_nr
(downloaded from www.cpndb.ca [16]). OTU abundance was
calculated based on mapping of sequence reads to OTU
sequences using Bow tie 2 in mPUMA. OTU having the same
database reference were collapsed into nearest neighbor
“species” and OTU with less than 55% identity to any reference
sequence were removed from the dataset as non-cpn60
sequence.
Community composition analysis
A number of parameters and characteristics were calculated
for each sample’s microbial community profile. Good’s
coverage estimates were determined using mothur [17].
Shannon’s diversity index, Simpson’s diversity index, Chao1
estimate, the number of observed species and Jackknifed beta
diversity were calculated with Quantitative Insights Into
Microbial Ecology (QIIME) software [18]. Phylogenetic-based
distance matrices and clusters were examined using Unifrac
[19] and a Bray-Curtis dissimilarity matrix was computed in R
using the vegan package [20,21].
Quantitative PCR (qPCR)
Absolute quantification of bacterial species of interest in each
sample was done by qPCR using primers and annealing
temperatures described in Table 1. Quantification of
Streptococcus pneumoniae was achieved by detection of the
lytA gene using a Taqman assay [22], while all other species-
specific assays were SYBR Green-based, targeting the cpn60
gene. SYBR Green assays were also used for total 16S rRNA
gene content estimation based on amplification of the V1-V3
region of the 16S rRNA gene [23], while an estimate of human
mitochondrial DNA content was based on quantification of the
cytochrome C oxidase subunit 1 (cox1) gene.
For all assays designed in this study (Table 1), the cpn60
sequence for each target species type strain was used to
design species-specific primers. Signature regions unique to
each target were determined using Signature Oligo software
(LifeIntel Inc., Port Moody, BC, Canada), primers were
designed with Beacon Designer software (Premier Biosoft
International, Palo Alto, CA, USA) and PrimerBLAST [24].
Primers were used to amplify target sequence from patient
DNA samples, which were then ligated into pGEM-T-Easy
Table 1. PCR primers and conditions used in this study.
Target Primer name Primer sequencea Anneal (°C) Reference
cpn60 H279 GAIIIIGCIGGIGAYGGIACIACIAC 40-60 [11]
 H280 YKIYKITCICCRAAICCIGGIGCYTT   
 H1612 GAIIIIGCIGGYGACGGYACSACSAC   
 H1613 CGRCGRTCRCCGAAGCCSGGIGCCTT   
Corynebacterium accolens (Ca) JH0366 AGAGTCCAATACCTTCGG 62 This study
 JH0367 CTCCTGACGCTCCATATC   
Corynebacterium pseudodiphtheriticum (Cp) JH0374 TGAACAAGGATTCCGTTA 58 This study
 JH0375 CAGGATGTATGGGTCTTC   
Enterococcus hirae (Eh) JH0144 TGCTCAAGTTGCAGCTGTTT 62 This study
 JH0145 TTCGGTTTCGATTCCTTTTG   
Staphylococcus aureus (Sa) JH0399 CTGAACTAGAAGTGGTTGAAGGT 67 This study
 JH0400 CGCATACGGTTTAGCACGATA   
Streptococcus pneumoniae (Sp) JH0380 ACGCAATCTAGCAGATGAAGCA 60 [22]
 JH0381 TCGTGCGTTTTAATTCCAGCT   
 JH0382(probe) (FAM)TGCCGAAAACGCTTGATACAGGGAG(BHQ1)   
Streptococcus mitis (Sm) JH0376 GCCGTCTCTTCTCGTTCT 62 This study
 JH0377 GGATTTTCAAGATCAGCTACCATT   
Propionibacterium acnes (Pa) JH0372 TATATCCTTATCGTCAACTCCAA 62 This study
 JH0373 CTCGGCAATGACAAACAG   
16S rRNA gene (16S) SRV3-1 CGGYCCAGACTCCTAC 62 [23]
 SRV3-2 TTACCGCGGCTGCTGGCAC   
Human cytochrome C oxidase subunit 1 (cox1) JH0241 CACCTTCTTCGACCCCGCCG 67 This study
 JH0242 TGCTTCCGTGGAGTGTGGCG   
a I = inosine, Y=C or T, R=G or A, K=G or T, S=G or C, FAM = Carboxyfluorescein, BHQ1 = Black hole quencher 1
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(Invitrogen) to make standards and facilitate confirmation of the
target by sequencing. Specificity of all primer pairs was tested
by using standard plasmids from other assays as template and
no products were generated. Finally, the optimal annealing
temperature for each assay was determined via an annealing
temperature gradient run and analysis.
All qPCR reactions were run on a plate containing a no
template control (NTC) and a standard curve composed of
target-containing plasmids at concentrations of 100 to 107
copies/reaction. All reactions were performed in duplicate.
Each reaction consisted of 1 × iQ SYBR Green Supermix
(BioRad, Mississauga, ON, Canada), 400 nM each primer and
2 µl of template DNA, in a final volume of 25 µl. A MyiQ
thermocycler (BioRad) was used for all reactions with the
following program: 95°C for 3 min, followed by 40 cycles of
95°C for 15 sec., annealing temperature (Table 1) for 15 sec.,
72°C for 15 sec., and a final extension at 72°C for 5 min. A
dissociation curve was subsequently run for 81 cycles at 0.5°C
increments from 55°C to 95°C for 30 sec at each time point.
Fluorescent signals were measured every cycle at the end of
the annealing step and continuously during the dissociation
curve data collection. The Taqman assay was run under
identical conditions, with the substitution of 1× iQ Supermix
(BioRad) in place of the SYBR Green Supermix, the addition of
200 nM JH0382 probe and the omission of the dissociation
curve. All resulting data was analyzed using iQ5 Optical
System Software (BioRad).
Correlations between quantified PCR copies and sequencing
read abundance were calculated with SPSS software (SPSS
Inc., Chicago, IL, USA).
Results
Pyrosequencing and quality control
cpn60 UT amplicon was generated from all 67 samples.
Amplicons were pooled into four libraries and each was
sequenced on a half plate region of a Roche 454 GS FLX
Titanium pyrosequencer to generate a total of 1,940,006 filter
passed sequence reads. Since previous studies of upper
respiratory samples report human genomic DNA as an
overwhelming proportion of nucleic acid isolated from this
environment [10,25], all filter passed sequences were screened
against a version of the human genome that had all cpn60
genes and pseudo-genes removed. This screening process
filtered out 1,661,090 sequences (85.6% of the data). The
remaining sequences were MID-separated and loaded into
gsAssembler for de novo assembly. OTU sequences were then
filtered to remove chimeras and non-cpn60 sequences (those
with <55% identity to any reference database sequence). OTU
abundance was calculated by mapping all reads on to the OTU
using Bow tie 2 within the mPUMA pipeline. The final dataset
contained 270,284 sequences in 490 OTU (Table S2). When
each OTU was compared to the reference database
(cpnDB_nr), the median percent identify of OTU to reference
sequences was 96.4%, with 369/490 (75%) of the OTU having
identities of >90% to a reference sequence (Table S3). To
further aggregate the data, OTU with the same nearest
neighbor (termed nearest neighbor "species") were combined.
An average of 4,158 sequence reads per sample (median
1054) was obtained. Samples flu36 and flu48 contained fewer
than 100 reads after processing and were removed from the
analysis. Raw sequence data files from the 65 samples used in
the study have been deposited to the NCBI Short Read
Archive, and are associated with the BioProject accession
PRJNA200951.
Sequencing depth cut-off
An initial cut-off of at least 100 high-quality cpn60 sequence
reads per sample was imposed on the dataset before analysis,
which resulted in two samples being removed from the study.
To evaluate whether this cut-off was sufficient to allow robust
analyses, jackknifed beta diversity was calculated by
generating 1000 rarefractions of the data at a depth of 100
reads for each of the remaining 65 samples. A distance matrix
was created for each rarefaction and principal coordinates
analysis (PCoA) was computed on each rarefied matrix using
two different distance measures: Bray-Curtis and Canberra.
Each sample was then plotted as a point where the area of
each point reflected the interquartile range of the jackknifed
PCoA estimates (Figure S1). The relatively compact size of the
points for each sample indicated that the distance matrices
were fairly consistent over 1000 iterations at the sampling
depth of 100 reads, suggesting the sampling depth was
adequate for sample comparison. As such, the 65 samples
profiled that exceeded this minimum were used for all further
analyses.
Diversity and overall composition measures
Since it is well-established that diversity statistics are
influenced by different sampling depths [26], values for the
Shannon’s diversity index, Simpson’s diversity index, Chao1
estimate and the observed number of species per sample were
all derived from the mean value of 1000 iterations of a 100 read
subsampling of nearest neighbor “species” values in each
sample. The diversity indices were then compared by patient
gender, age, health authority, sample type and STAT/non-
STAT designation by ANOVA (Table S4). Microbiomes
contained an average of 9-14 nearest neighbor “species” when
examined at the 100 read subsampling depth, and were
predicted by the Chao1 estimate to contain 13-20 “species” if
sampled to completion. There was no significant difference in
the number of species observed or predicted between any
patient characteristic groups. Diversity measurements of
richness and evenness determined by Shannon’s and
Simpson’s indices also showed no statistically significant
difference by patient characteristics. However, there was a
trend for both measures to increase as patient age increased
(Shannon’s, p = 0.08; Simpson’s, p = 0.11; Table S4), with an
observable distinction between patients under and over 20
years of age.
Unifrac clustering, considering both phylogenetic
composition of the microbiome and normalized sequence read
abundance of the 215 nearest neighbor “species” sequences in
each sample, was performed (Figure S2). There were no
meaningful groupings of upper respiratory tract microbiomes
based on our five patient characteristics. As such, there
Upper Respiratory Microbiota of H1N1 Patients
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appeared to be no major phylogenetic differences in the
microbiome compositions between patients based on these
variables.
Phylum-level comparisons
The phylogenetic composition of the combined upper
respiratory tract microbiome dataset consisted of Firmicutes
(42.5%), Proteobacteria (27.7%), Actinobacteria (21.7%),
Bacteroides (5.5%), Fungi (0.1%), Human (0.2%) and other
bacteria (2.3%) (Figure S3). Individual microbiomes were
dominated by either Firmicutes, Actinobacteria or
Proteobacteria (Figure 1), consistent with previous reports of
human upper respiratory tract microbiomes [5–8].
To identify if a particular microbiome composition was
associated with a patient characteristic, the proportion of each
phylum in each sample was calculated and samples from the
same group were averaged together (Figure 1). No statistically
significant differences were observed in the microbiome
compositions grouped by any variable investigated.
Species-level microbial comparisons
To investigate the microbiome at a finer taxonomic
resolution, the nearest neighbor “species” description of each
sample was used to construct a Bray-Curtis dissimilarity matrix.
The matrix was calculated by converting the number of
sequence reads for each “species” in a sample to its relative
abundance within that sample. The jackknife beta diversity
analysis results (Figure S1) suggested that the distances
between samples were fairly robust, so the actual sequence
counts, rather than rarefied numbers, were used for this
analysis. Average linkage hierarchical clustering of the
dissimilarity matrix generated 11 clusters (Figure 2). There
were five clusters consisting of only one or two patient samples
(clusters 5, 8, 9, 10 and 11). Cluster 1 was the largest, with 27
patients with Variovorax paradoxus and Enterococcus hirae as
the dominant organisms. Clusters 2 and 4 were the next
largest, each containing 10 patients, with Corynebacterium
pseudodiphtheriticum and Streptococcus pneumoniae as the
dominant organisms, respectively.
Absolute quantification of targets
To assess the reliability of sequence read abundance from
pyrosequencing of the cpn60 gene, we chose seven species
from the dataset to evaluate by quantitative real-time PCR
(qPCR). This set was comprised of the three most abundant
species in the dataset (Staphylococcus aureus, Streptococcus
pneumoniae and Corynebacterium pseudodiphtheriticum), two
species representing 1-2% of the dataset (Enterococcus hirae
and Propionibacterium acnes) and two species present at less
than 1% of the dataset (Streptococcus mitis and
Corynebacterium accolens) (Table 2). All seven of these
species were also detected in at least 31/65 samples. In
addition to the individual species, estimates of total bacterial
and human DNA were also obtained for comparison. qPCR
was used to quantify the amount of each target of interest in
the clinical sample nucleic acid extracts. A well-established
Taqman assay targeting the lytA gene was used for
quantification of Streptococcus pneumoniae [22]. For the
remaining species, specific assays were developed for this
study using SYBR Green chemistry and targeting the species
type strain cpn60 sequence (whenever available). Assays were
also designed to estimate the amount of total bacterial DNA
(via quantification of the 16S rRNA gene content with primers
designed previously [23]) and human DNA present (via
quantification of human mitochondrial cytochrome C oxidase
subunit 1 gene (cox1)).
The numbers of copies per sample of all targets were
determined (Figure 3). The human cox1 gene had, on average,
an abundance 2.6 logs higher that the bacterial 16S rRNA
gene (Figure 3, Human compared to 16S). The expected copy
number of cox 1 per cell is 50-2000 based on estimates of
approximately 42 mitochondria per mammalian epithelial cell
[27] and 1-50 mitochondrial genomes per mitochondrion [28].
An average of approximately 1.0×108 copies of cox1 were
detected per sample, which translates into 5.0×104 to 2.0×106
epithelial cells per sample (Figure 3). The average 16S rRNA
copy number per sample was 2.5×105 (Figure 3), which
translates to approximately 7.5×105 bacteria per sample based
on a median 16S rRNA copy number of three per bacterial
genome [14]. Finally, taking into consideration that an epithelial
cell has significantly more DNA than a bacterial cell, it is
evident that the standard clinical upper respiratory tract
samples used in this study were overwhelmingly dominated by
host DNA.
Comparing sequence read abundance to absolute
quantification
To determine how well pyrosequencing read abundance
reflected absolute quantities per sample for the species
targeted by qPCR, sequence abundance counts were
compared to qPCR target copies per sample using a
Spearman’s rho correlation (Table 2). With the exception of
Streptococcus mitis, all species had a significant positive
correlation (p < 0.05) between their sequence read abundance
and their absolute quantification values. The S. mitis correlation
was just outside the range of significance (p = 0.055) and could
be due to qPCR assay biases, such as being too specific
(missing natural species variation) or not specific enough
(cross-reacting with other organisms). Alternatively, the original
cpn60 UT PCR may not have been optimal for this species and
S. mitis amplicons may have been underrepresented in the
sequencing data.
Discussion
Our objective was to characterize the upper respiratory tract
microbiomes in patients with A(H1N1) pdm09 influenza A and
determine if patient age, gender, health authority, sample type
and whether the sample was collected in a hospital or not were
associated with differences in microbiome composition. To
determine this, the first step was to determine the microbiomes
of patients confirmed A(H1N1) pdm09 positive. To facilitate the
exploitation of any informative differences in future diagnostics,
we chose samples for this study from specimens submitted to
the BC PHMRL for routine influenza diagnostic testing. This
meant that the samples were from a range of health authorities
across the province, collected from a spectrum of patients in
Upper Respiratory Microbiota of H1N1 Patients
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Figure 1.  Sample composition at the phylum level.  Phylum level profiles are shown for individual patients (n=65) as well as the
average phylum proportions for sample designation (STAT/non-STAT), gender, health authority, patient age (in years) and sample
type.
doi: 10.1371/journal.pone.0069559.g001
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terms of gender, age, preexisting conditions, and that sample
type varied from nasal swabs to nasopharyngeal swabs to
nasopharyngeal washes and one tracheal aspirate. An
important part of our study was to determine whether this
heterogeneous sample pool (which would be typically received
by a diagnostic laboratory) would yield useful information about
the upper respiratory tract microbiome.
Figure 2.  Hierarchical clustering of sample profiles.  (A) Nearest neighbor “species” composing 20% or more of the microbiome
in at least one sample are shown. The average percent identities of sequence reads within each nearest neighbor are given in
parenthesis. The color scale (black to red) reflects an increasing relative abundance of sequence reads for each nearest neighbor
“species” in each sample. (B) Summary of the hierarchical clustering detailing the number of samples and dominant organism(s) in
each cluster.
doi: 10.1371/journal.pone.0069559.g002
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Bacterial pneumonia is a major cause of morbidity and
mortality associated with influenza [3], and Streptococcus
pneumoniae coinfection has been previously implicated in
A(H1N1) pdm09 influenza illness severity [4]. Our ability to
assess patient illness severity in this study was limited. During
the pandemic, the BC PHMRL established a system to
prioritize testing for patients with more severe illness where
samples submitted for influenza testing from patients
hospitalized for respiratory illness, severe respiratory infection
or having lower respiratory tract symptoms were to be marked
with a “STAT” designation. The “non-STAT” samples in our
study were collected in a community setting from patients well
enough to see a physician at a private office or clinic, and
submitted for influenza testing as routine samples. However, as
the pandemic progressed, almost all samples from patients
attended to at the hospitals were designated “STAT”,
regardless of disease severity. As such, we were unable to
separate mildly and severely ill patients confidently, and could
only use this characteristic as an indicator for the clinical
setting in which the sample was collected.
No statistically significant differences were detected between
phylum level upper respiratory tract microbiomes generated in
this study when data was grouped by any of the five patient
and sample variables examined (Figure 1). There were no
significant differences by ANOVA comparing upper respiratory
tract microbiome diversity statistics such as observed species,
Chao1 estimates or Shannon’s and Simpson’s diversity index
when compared using these variables (Table S4). As well, at a
phylogenetic level, Unifrac failed to cluster microbiome
compositions by these metadata parameters (Figure S2). The
only trend noted was a moderate difference in microbiome
richness and diversity between younger (<20 years) and older
(>20 years) patients (Table S4). In fact, the finding that both
men and women from birth to over 65 years of age share a
remarkably similar collection of upper respiratory tract bacteria
and fungi is impressive and notably different from what has
been observed for the microbiota of other body sites [29].
The upper respiratory tract microbiome profiles generated in
this study are somewhat consistent with previous culture-
independent surveys generated from the nose/nasopharynx of
healthy individuals (Figure 1). Frank et al. used the V1-V4
Table 2. Correlation between normalized pyrosequencing
read abundance and qPCR absolute quantity by
Spearman’s rho coefficient.
Target species
Proportion of
total dataset
(%)
Sample
prevalencea
Correlation between
read abundance &
qPCR
Staphylococcus aureus 19.08 61 ρ = 0.325, p = 0.008
Streptococcus
pneumoniae 14.60 51 ρ = 0.469, p = 0.000
Corynebacterium
pseudodiphtheriticum 12.98 43 ρ = 0.475, p = 0.000
Enterococcus hirae 2.18 52 ρ = 0.432, p = 0.000
Propionibacterium acnes 1.13 53 ρ = 0.354, p = 0.004
Streptococcus mitis 0.69 31 ρ = 0.239, p = 0.055
Corynebacterium
accolens 0.39 36 ρ = 0.458, p = 0.000
a Number of samples (out of 65 total), based on sequence read abundance.
Figure 3.  Quantification of bacterial and human mitochondrial DNA.  Box and whisker plots showing target copies per sample
detected (n = 65). Ca - Corynebacterium accolens; Cp - Corynebacterium pseudodiphtheriticum; Eh - Enterococcus hirae; Pa -
Propionibacterium acnes; Sa - Staphylococcus aureus; Sp - Streptococcus pneumoniae; Sm - Streptococcus mitis; 16S -16S rRNA
gene; Human - human cytochrome C oxidase gene.
doi: 10.1371/journal.pone.0069559.g003
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region of the 16S rRNA gene to profile the bacterial
communities in the left and right nares of five healthy and 44
hospitalized individuals. Generating an average of 268
sequence reads per sample, they determined the major phyla
present in the noses of healthy individuals to be Actinobacteria
(68%), Firmicutes (27%), Proteobacteria (4%) and
Bacteriodetes (1.4%), while hospitalized individuals had
Firmicutes dominant (71%) profiles, with proportionately fewer
Actinobacteria (20%) [6]. Lemon et al. profiled the nasal
communities from seven healthy individuals by amplifying the
full-length 16S rRNA gene from samples and identified
community members by PhyloChip analysis. They observed an
inverse correlation between the proportions of Firmicutes and
Actinobacteria detected in an individual’s nostril microbiome.
When Staphylococcaceae (Firmicutes) proportions were high,
Corynebacteraceae and/or Propionibacteriaceae
(Actinobacteria) proportions were low and vice versa [7]. Our
dataset of 65 patients, with an average of 4158 sequences per
sample, contained many samples dominated by Actinobacteria
or Firmicutes, but also contained several profiles dominated by
Proteobacteria (Figure 1). Although Proteobacteria were clearly
seen in the previous studies, our Proteobacteria proportions
were notably higher. At lower taxonomic levels (family, genus,
species), many major organisms detected from our A(H1N1)
pdm09 study subjects (Corynebacterium, Propionibacterium,
Staphylococcus and Streptococcus) are comparable to
previous surveys [5–8]. In addition, our dataset also contained
several Proteobacteria genera, such as Variovorax and
Moraxella, not as commonly reported in this environment by
16S rRNA gene-based studies.
The only study to date that has investigated the upper
respiratory tract microbiome from A(H1N1) pdm09 influenza A
patients was Greninger et al., during their RNA metagenome
profiling study [10]. Bacterial data in this study was limited to
rRNA gene sequence obtained from Illumina sequencing of
total cDNA libraries. Interestingly, their finding of
Proteobacteria-dominated microbiomes was mirrored in our
results. The two bacterial families that dominated the
microbiomes of over half of their patients, Enterobactericeae
(7/17 patients) and Moraxellaceae (4/17 patients), were seen
as the dominant families for Clusters 11 and 7 in our data,
respectively (Figure 2). Collectively, these finding lend weight
to a hypothesis that influenza A infection may be associated
with a more Proteobacteria-dominated upper respiratory tract
microbiome. However, additional studies addressing this
hypothesis are needed before any definitive statements can be
made.
One new avenue our study explored was the composition of
eukaryotic members of the upper respiratory tract microbiome.
While all previous studies used the 16S rRNA gene as a target,
cpn60 has the advantage of being present in both bacteria and
eukaryotes, making simultaneous detection possible. In these
samples, Fungi did not represent a large proportion of the
sequence reads obtained (0.1%), however three fungal species
were identified, including Malassezia globosa (skin organism
known to cause dandruff [30]), Penicillium digitatum (the cause
of green mold on citrus fruit [31]) and Phanerochaete
chrysosporium (environmental organism that decomposes
wood [32]) (Table S3). Whether these fungi were just transients
in the upper respiratory tract or whether they play a role in the
microbiome is currently unknown.
Another technical aspect we sought to investigate was the
reliability of sequence read counts as a marker of actual
organism abundance. Evidence has been accumulating in the
literature highlighting PCR, sequencing and data processing
limitations that generate misleading and artifactual estimates of
taxon abundance based solely on sequencing read abundance
counts from metagenomic profiles [26,33,34]. The cpn60 UT
region has been shown to alleviate some of these biases with
strategic primer design [11,35], however, this is the first study
to employ cpn60 for upper respiratory tract analysis, and so a
technical examination of its performance was desired. We were
surprised that 85% of our sequence data ended up matching
the human genome, suggesting a significant amount of non-
target amplification. The cpn60 PCR protocol used in this study
has been previously applied to clinical samples from feces and
vaginal swabs with no problems in specificity [36,37]. This led
us to evaluate the relative proportions of human to bacterial
DNA in these upper respiratory tract samples (Figure 3). Given
that the human DNA component of these samples was an
order of magnitude higher than the bacterial component, we
suspect that the lower range of the temperature gradient
component of the cpn60 universal PCR (originally designed for
maximum amplification of diverse bacteria [11]) allowed for the
non-specific amplification. Studies are underway to evaluate
this parameter and address this issue for future studies
involving samples dominated by host genomic DNA.
With our remaining data, we sought to determine if the
microbial cpn60 sequences we obtained were actually
proportional and representative of the species present in the
samples, independent of the non-specific amplification. To that
end, we chose seven organisms that represented the most
abundant species in the dataset (13-19% of the sequence
data), species representing 1-2% of the data and species
representing less than 1% of the data (Table 2). These species
were specifically targeted and quantified by qPCR.
Reassuringly, the sequence abundance data generated with
cpn60 profiling correlated strongly with absolute species
quantification by targeted qPCR (Table 2). Methodologically,
this was very important and gives confidence in the analyses
based on the read abundance values. Many metagenomic
profiling studies draw conclusions from sequence abundance
data but findings are never validated with another method.
Conclusion
Investigation of microbiomes from A(H1N1) pdm09 patients
showed that patient gender, originating healthy authority,
sample type collected or sample designation as STAT/non-
STAT were not consistently associated with upper respiratory
tract microbiome structure. There was a trend for patients to
have moderately more richness and diversity in their
microbiomes with increasing age (particularly between patients
younger and older than 20 years). At the phylum level,
A(H1N1) pdm09 patients had microbiomes composed of
Actinobacteria, Firmicutes and Proteobacteria while at the
species level, microbiome compositions fell into one of 11
clusters dominated by one or two organisms. Finally, the cpn60
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sequence read abundances generated in this study were
validated by targeted qPCR of a select group of prevalent
species.
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